Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marcel Gerebernus Maria Luyckx is active.

Publication


Featured researches published by Marcel Gerebernus Maria Luyckx.


Bioorganic & Medicinal Chemistry Letters | 2002

Synthesis and anti-angiogenic activity of 6-(1,2,4-thiadiazol-5-yl)-3-amino pyridazine derivatives

Jean-Pierre André Marc Bongartz; Raymond Antoine Stokbroekx; Marcel Jozef Maria Van Der Aa; Marcel Gerebernus Maria Luyckx; Marc Willems; Marc Ceusters; Lieven Meerpoel; Gerda Smets; Tine Jansen; Walter Wouters; Charlie Bowden; Lisa Valletta; Mark Herb; Rose Tominovich; Robert W. Tuman

General screening for inhibitors of microvessel growth in vitro in the rat aortic ring assay led to the discovery of a novel series of thiadiazole pyridazine compounds with potential anti-angiogenic activity. Chemical optimization produced orally active compounds with potent in vitro and in vivo anti-angiogenesis and anti-tumor activities.


Archive | 1985

Anti-virally active pyridazinamines

Raymond Antoine Stokbroekx; Marcel Jozef Maria Van Der Aa; Joannes Josephus Maria Willems; Marcel Gerebernus Maria Luyckx


Journal of Medicinal Chemistry | 1985

New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines

Frans Eduard Janssens; Joseph Leo Ghislanus Torremans; Marcel Janssen; Raymond Antoine Stokbroekx; Marcel Gerebernus Maria Luyckx; Paul A. J. Janssen


Archive | 1997

Angiogenesis inhibiting pyridazinamines

Raymond Antoine Stokbroekx; Der Aa Marcel Jozef Maria Van; Marc Willems; Lieven Meerpoel; Marcel Gerebernus Maria Luyckx; Robert W. Tuman


Archive | 1979

N-Heterocyclyl-4-piperidinamines

Frans Eduard Janssens; Raymond Antoine Stokbroekx; Joseph Leo Ghislanus Torremans; Marcel Gerebernus Maria Luyckx


Journal of Medicinal Chemistry | 1985

New antihistaminic N-heterocyclic 4-piperidinamines. 3. Synthesis and antihistaminic activity of N-(4-piperidinyl)-3H-imidazo[4,5-b]pyridin-2-amines.

Frans Eduard Janssens; Joseph Leo Ghislanus Torremans; Marcel Janssen; Raymond Antoine Stokbroekx; Marcel Gerebernus Maria Luyckx; Paul A. J. Janssen


Drug Development Research | 1986

Levocabastine (R 50547): The prototype of a chemical series of compounds with specific H1‐antihistaminic activity

Raymond Antoine Stokbroekx; Marcel Gerebernus Maria Luyckx; Johan J. Willems; Marcel Janssen; Johan O. M. M. Bracke; Robert L. P. Joosen; Jean Pierre Frans Van Wauwe


Archive | 1979

N-Heterocyclyl-4-piperidinamines, methods for their preparation, pharmaceutical compositions comprising them, intermediates therefor, and method for the preparation of the intermediates

Frans Eduard Janssens; Raymond Antoine Stokbroekx; Joseph Leo Ghislanus Torremans; Marcel Gerebernus Maria Luyckx


Journal of Medicinal Chemistry | 1985

New antihistaminic N-heterocyclic 4-piperidinamines. 2. Synthesis and antihistaminic activity of 1-[(4-fluorophenyl)methyl]-N-(4-piperidinyl)-1H-benzimidazol-2-a mines.

Frans Eduard Janssens; Joseph Leo Ghislanus Torremans; Marcel Janssen; Raymond Antoine Stokbroekx; Marcel Gerebernus Maria Luyckx; Paul A. J. Janssen


Archive | 1985

Benzoxazol- and benzothiazolamine derivatives

Raymond Antoine Stokbroekx; Marcel Gerebernus Maria Luyckx; Frans Eduard Janssens

Collaboration


Dive into the Marcel Gerebernus Maria Luyckx's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge